Cardiovascular Health Basic

A focused cardiovascular risk panel measuring HbA1c, a full lipid profile, homocysteine, fasting insulin, fasting glucose, and high-sensitivity CRP. Goes beyond standard cholesterol testing to assess insulin resistance and inflammation — two key drivers of cardiovascular disease that are often undetected in routine screening.

Cardiovascular disease remains the leading cause of death in Australia, responsible for approximately 25% of all deaths annually. This panel goes well beyond the standard lipid profile by including markers of inflammation, insulin resistance, and long-term glucose control — three critical risk factors that are frequently undetected in routine screening. HbA1c measures average blood glucose levels over the preceding 2-3 months, providing a more reliable picture than a single fasting glucose reading. Even in the pre-diabetic range, elevated HbA1c is associated with increased cardiovascular risk. Fasting insulin adds further resolution — insulin levels may rise years before glucose becomes abnormal, making it one of the earliest detectable signs of metabolic dysfunction. Homocysteine is an amino acid that, when elevated, is associated with increased risk of cardiovascular events and may indicate functional deficiencies in folate, B12, or B6. High-sensitivity CRP (hs-CRP) measures low-grade systemic inflammation, which is increasingly recognised as a driver of atherosclerotic plaque formation independent of cholesterol levels. Some cardiologists consider hs-CRP as important as LDL cholesterol for risk stratification. This panel is particularly valuable for individuals with a family history of heart disease, those with metabolic syndrome risk factors (central obesity, high blood pressure, elevated triglycerides), or anyone who wants a more nuanced cardiovascular risk assessment than a basic cholesterol check provides.